Kyntra Bio, Inc.
KYNB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000921299
No open-market purchases or sales by Kyntra Bio, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $7.54M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Kyntra Bio, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 111
- +11 vs. Q4 2023
- Shares held
- 61.3M
- −8.75M (−12.5%) vs. Q4 2023
- Total value
- $143.9M
- +$81.8M (+131.7%) vs. Q4 2023
- New holders
- 25
- 26 more added
- Sold out
- 14
- 42 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $7.54M |
| Q1 2026 | 32 | $7.01M |
| Q4 2025 | 34 | $10.1M |
| Q3 2025 | 32 | $13.9M |
| Q2 2025 | 30 | $5.62M |
| Q1 2025 | 56 | $10.2M |
| Q4 2024 | 70 | $19.2M |
| Q3 2024 | 72 | $18.3M |
| Q2 2024 | 102 | $50.4M |
| Q1 2024 | 111 | $143.9M |
| Q4 2023 | 100 | $62.1M |
| Q3 2023 | 110 | $59.0M |
| Q2 2023 | 153 | $207.9M |
| Q1 2023 | 173 | $1.42B |
| Q4 2022 | 145 | $1.20B |
| Q3 2022 | 152 | $950.1M |
| Q2 2022 | 152 | $746.9M |
| Q1 2022 | 158 | $816.6M |
| Q4 2021 | 164 | $934.6M |
| Q3 2021 | 165 | $656.8M |
| Q2 2021 | 176 | $1.80B |
| Q1 2021 | 199 | $2.47B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Kyntra Bio, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 2,013,768 | $4.73M | 0.00% | −376,913−15.8% | Reduced |
| Geode Capital Management, LLC | 2,074,666 | $4.88M | 0.00% | +56,385+2.8% | Added |
| State Street Corp | 2,162,877 | $5.08M | 0.00% | +352,197+19.5% | Added |
| Jacobs Levy Equity Management, Inc | 2,207,608 | $5.19M | 0.02% | −281,898−11.3% | Reduced |
| Acadian Asset Management LLC | 2,503,865 | $5.88M | 0.02% | +34,937+1.4% | Added |
| Vanguard Group Inc | 6,436,924 | $15.1M | 0.00% | −607,225−8.6% | Reduced |
| BlackRock Inc. | 6,967,918 | $16.4M | 0.00% | −237,382−3.3% | Reduced |
| Armistice Capital, LLC | 7,936,000 | $18.6M | 0.50% | −1,828,000−18.7% | Reduced |
| Primecap Management Co | 14,421,158 | $33.9M | 0.03% | −50,770−0.4% | Reduced |
| State Board of Administration of Florida Retirement System | 29,646 | – | – | +5,658+23.6% | Added |
| Mirae Asset Global Investments Co., Ltd. | 55,811 | – | – | +55,811 | New |
| HRT Financial LP | 0 | $0 | 0.00% | −355,770−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −244,083−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −126,200−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −61,274−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −48,199−100.0% | Sold out |
| Fiera Capital Corp | 0 | $0 | 0.00% | −44,586−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −41,546−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −32,190−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −26,701−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −24,100−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −15,450−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −9,250−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −379−100.0% | Sold out |